STAAR Surgical Gross Margin 2010-2024 | STAA
Current and historical gross margin for STAAR Surgical (STAA) over the last 10 years. The current gross profit margin for STAAR Surgical as of September 30, 2024 is %.
| STAAR Surgical Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2024-09-30 |
$0.34B |
$0.27B |
78.59% |
| 2024-06-30 |
$0.33B |
$0.26B |
79.52% |
| 2024-03-31 |
$0.33B |
$0.26B |
79.08% |
| 2023-12-31 |
$0.32B |
$0.25B |
78.88% |
| 2023-09-30 |
$0.31B |
$0.24B |
78.39% |
| 2023-06-30 |
$0.31B |
$0.24B |
78.10% |
| 2023-03-31 |
$0.30B |
$0.23B |
78.64% |
| 2022-12-31 |
$0.28B |
$0.22B |
78.52% |
| 2022-09-30 |
$0.28B |
$0.22B |
78.14% |
| 2022-06-30 |
$0.26B |
$0.20B |
77.78% |
| 2022-03-31 |
$0.24B |
$0.19B |
77.69% |
| 2021-12-31 |
$0.23B |
$0.18B |
77.39% |
| 2021-09-30 |
$0.22B |
$0.17B |
76.96% |
| 2021-06-30 |
$0.21B |
$0.16B |
76.21% |
| 2021-03-31 |
$0.18B |
$0.13B |
73.74% |
| 2020-12-31 |
$0.16B |
$0.12B |
72.39% |
| 2020-09-30 |
$0.16B |
$0.11B |
72.44% |
| 2020-06-30 |
$0.15B |
$0.11B |
72.30% |
| 2020-03-31 |
$0.15B |
$0.11B |
73.86% |
| 2019-12-31 |
$0.15B |
$0.11B |
74.17% |
| 2019-09-30 |
$0.14B |
$0.11B |
74.13% |
| 2019-06-30 |
$0.14B |
$0.10B |
74.26% |
| 2019-03-31 |
$0.13B |
$0.10B |
73.85% |
| 2018-12-31 |
$0.12B |
$0.09B |
73.39% |
| 2018-09-30 |
$0.12B |
$0.09B |
72.03% |
| 2018-06-30 |
$0.11B |
$0.08B |
71.56% |
| 2018-03-31 |
$0.10B |
$0.07B |
70.10% |
| 2017-12-31 |
$0.09B |
$0.06B |
71.11% |
| 2017-09-30 |
$0.09B |
$0.06B |
72.41% |
| 2017-06-30 |
$0.08B |
$0.06B |
72.62% |
| 2017-03-31 |
$0.08B |
$0.06B |
73.49% |
| 2016-12-31 |
$0.08B |
$0.06B |
71.95% |
| 2016-09-30 |
$0.08B |
$0.06B |
71.60% |
| 2016-06-30 |
$0.08B |
$0.06B |
70.00% |
| 2016-03-31 |
$0.08B |
$0.05B |
67.95% |
| 2015-12-31 |
$0.08B |
$0.05B |
67.95% |
| 2015-09-30 |
$0.07B |
$0.05B |
63.51% |
| 2015-06-30 |
$0.07B |
$0.05B |
63.01% |
| 2015-03-31 |
$0.07B |
$0.05B |
64.86% |
| 2014-12-31 |
$0.08B |
$0.05B |
65.33% |
| 2014-09-30 |
$0.08B |
$0.05B |
68.83% |
| 2014-06-30 |
$0.08B |
$0.05B |
69.74% |
| 2014-03-31 |
$0.07B |
$0.05B |
70.27% |
| 2013-12-31 |
$0.07B |
$0.05B |
70.83% |
| 2013-09-30 |
$0.07B |
$0.05B |
71.01% |
| 2013-06-30 |
$0.07B |
$0.05B |
70.59% |
| 2013-03-31 |
$0.07B |
$0.05B |
69.70% |
| 2012-12-31 |
$0.06B |
$0.04B |
68.75% |
| 2012-09-30 |
$0.06B |
$0.04B |
68.75% |
| 2012-06-30 |
$0.06B |
$0.04B |
68.25% |
| 2012-03-31 |
$0.06B |
$0.04B |
68.25% |
| 2011-12-31 |
$0.06B |
$0.04B |
67.74% |
| 2011-09-30 |
$0.06B |
$0.04B |
66.67% |
| 2011-06-30 |
$0.06B |
$0.04B |
65.52% |
| 2011-03-31 |
$0.06B |
$0.04B |
64.29% |
| 2010-12-31 |
$0.06B |
$0.04B |
63.64% |
| 2010-09-30 |
$0.05B |
$0.03B |
62.96% |
| 2010-06-30 |
$0.05B |
$0.03B |
64.15% |
| 2010-03-31 |
$0.05B |
$0.03B |
63.46% |
| 2009-12-31 |
$0.05B |
$0.03B |
64.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$1.521B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
